Since June 2025, Vertex Pharmaceuticals has been in a holding pattern, posting a small return of 0.5% while floating around ...

These stocks have promising assets in their portfolios that could help make their valuations soar in the future.

The best defensive stocks to balance risk and return combine durable cash flows, essential services, and key growth metrics.

India - Pre-Grant Opposition Not Permitted After Signing Of Grant: Delhi High Court Affirms. Legal News and Analysis - India ...

In the latest close session, Vertex Pharmaceuticals (VRTX) was down 1.2% at $449.52. This change lagged the S&P 500's 1.16% loss on the day. Meanwhile, the Dow experienced a drop of 0.47%, and the ...

The investment firm co-led a $125 million Series A round for Ambros Therapeutics, a Vivek Ramaswamy co-founded company with a ...

BENTONVILLE, Ark., Dec. 17, 2025 /PRNewswire/ -- HFA Architecture + Engineering announced today that Sherwood Butler has joined the employee-owned firm as Vice President. He will lead HFA's growing ...

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a pre-existing royalty interest in Nuvalent's neladalkib and zidesamtinib from an undisclosed ...

Founded in 1964, Alger is recognized as a pioneer of growth-style investment management. Privately-owned and headquartered in New York City, Alger can help "Unlock Your Growth Potential" through a ...

If the trends of the first three quarters continue in the fourth, the amount of money raised by Bay State startups could be ...